iShares Biotechnology ETF
837 hedge funds and large institutions have $5.11B invested in iShares Biotechnology ETF in 2023 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 201 increasing their positions, 311 reducing their positions, and 65 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
837
Holders Change
-22
Holders Change %
-2.56%
% of All Funds
13.2%
Holding in Top 10
11
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-21.43%
% of All Funds
0.17%
New
51
Increased
201
Reduced
311
Closed
65
Calls
$233M
Puts
$234M
Net Calls
-$1.01M
Net Calls Change
+$52.9M
Top Buyers
| 1 |
Millennium Management
New York
|
$48.4M |
| 2 |
Citigroup
New York
|
$299M |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
$31.3M |
| 4 |
UBS Group
Zurich,
Switzerland
|
$196M |
| 5 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
$17M |
